Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Journal of Market Access & Health Policy|August 28, 2024
Valuation of Medical Innovation Handling with Uncertainty and RiskMark Nuijten, Stefano CapriClinical Therapeutics|July 16, 2003
Cost-minimization analysis of pegylated liposomal doxorubicin versus topotecan for the treatment of ovarian cancer in ItalyStefano Capri, Giulio CattaneoCurrent Medical Research and Opinion|July 12, 2005
Cost-effectiveness in Italy of preventive treatment with ramipril in patients at high risk of cardiovascular eventsStefano Capri, Stefano PerliniJournal of Market Access & Health Policy|December 14, 2020
Pricing of orphan drugs in oncology and rare diseasesMark Nuijten, Stefano CapriJournal of Market Access & Health Policy|June 13, 2022
An integrated valuation model for payer and investorMark Nuijten, Stefano CapriBMC Health Services Research|January 27, 2017
Cost of breast cancer based on real-world data: a cancer registry study in ItalyStefano Capri, Antonio RussoExpert Review of Pharmacoeconomics & Outcomes Research|February 23, 2023
The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approachStefano Capri, Fernando Antoñanzas, Rosella LevaggiClinical Therapeutics|February 13, 2017
Cost-effectiveness of Pazopanib Versus Sunitinib as First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma from an Italian National Health Service PerspectiveStefano Capri, Camillo Porta, Thomas E DeleaJournal of Medical Economics|December 21, 2019
A cost-effectiveness and budget impact analysis of apremilast in patients with psoriatic arthritis in ItalyStefano Capri, A Migliore, F Loconsole, et al.Human Vaccines & Immunotherapeutics|February 10, 2018
Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian populationStefano Capri, Marco Barbieri, Chiara de Waure, et al.Pageof 4